Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • Qué esperar de la inmunoterapia contra el cáncer en 2021: COVID-19, biomarcadores y modelos de ensayos clínicos

    El Dr. Kunle Odunsi comparte sus reflexiones sobre el futuro en el campo de la inmunoterapia contra…

    April 6, 2021| CRI Staff
  • Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer

    Presentamos a algunas de las muchas mujeres que fueron y son fundamentales para el CRI y la…

    March 24, 2021| CRI Staff
  • Marcando el rumbo a seguir: la Directora Ejecutiva del CRI analiza 2020 y el prometedor futuro

    La Directora Ejecutiva del CRI, la Dra. Jill O’Donnell-Tormey, Ph. D., habla sobre los avances de la…

    March 9, 2021| CRI Staff
  • Kidney Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This March for Kidney Cancer Awareness Month, we look at new research, new treatments, and how we’re…

    March 7, 2021| CRI Staff
  • Colorectal Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This March for Colorectal Cancer Awareness Month, we look at new research, new treatments, and how we’re…

    March 5, 2021| CRI Staff
  • Multiple Myeloma Awareness Month: 2021 Immunotherapy Research Updates

    This March for Multiple Myeloma Awareness Month, we look at new research, new treatments, and how we’re…

    March 4, 2021| CRI Staff
  • Combustible para la lucha: el efecto del metabolismo del cáncer sobre el sistema inmunitario, con el Dr. Greg Delgoffe

    Greg Delgoffe, beneficiario del programa Lloyd J. Old STAR del CRI, está investigando el efecto del metabolismo…

    March 3, 2021| CRI Staff
  • Dr. Terence Friedlander Answers Questions on Bladder Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit

    Terence Friedlander, MD, answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient…

    January 18, 2021| CRI Staff
  • Dr. Elizabeth M. Jaffee Answers Questions on Pancreatic Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit

    Dr. Elizabeth Jaffee answers questions on immunotherapy for pancreatic cancer from the 2020 CRI Virtual Immunotherapy Patient…

    January 15, 2021| CRI Staff

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal